Skip to main content
. 2024 Oct 7;11:1426531. doi: 10.3389/fcvm.2024.1426531

Table 1.

Baseline characteristics of the study population at the time of de-novo AFCA according to extra-PV triggers.

De-novo AFCA
Overall Extra-PV trigger (-) Extra-PV trigger (+) p-value
Total, n 2,036 1,783 253
Age, years 59 (52–67) 59 (51–67) 61 (54–68) 0.009
Female 573 (28.1) 483 (27.1) 90 (35.6) 0.006
Paroxysmal AF 1,373 (67.4) 1,209 (67.8) 164 (64.8) 0.381
BMI, kg/m2 24.7 (22.9–26.6) 24.7 (22.9–26.7) 24.4 (22.7–26.4) 0.180
Comorbidity
HTN 915 (44.9) 799 (44.8) 116 (45.8) 0.808
DM 291 (14.3) 258 (14.5) 33 (13.0) 0.610
Heart failure 271 (13.3) 233 (13.1) 38 (15.0) 0.449
Vascular disease 222 (10.9) 205 (11.5) 17 (6.7) 0.030
Echocardiography parameter
EF,% 64.0 (59.0–68.0) 64.0 (59.0–69.0) 64.0 (60.0–68.0) 0.903
E/e’ 9.0 (7.4–12.0) 9.0 (7.3–12.0) 9.4 (8.0–12.0) 0.098
LAVI, ml/m2 34.5 (27.5 34.0 (27.3–42.9) 37.4 (29.6–48.9) <0.001
Empirical linear ablation
Extra-PV LA linear line 780 (38.3) 648 (36.3) 132 (52.2) <0.001
Extra-PV RA linear line 1,489 (73.1) 1,274 (71.5) 215 (85.0) <0.001
Medication
RAAS inhibitors 697 (34.3) 605 (34.0) 92 (36.4) 0.500
Beta blockers 624 (30.7) 553 (31.1) 71 (28.1) 0.370
Heart rate variability (n = 1,293)
Mean heart rate, bpm 74 (66–82) 74 (67–82) 71 (63–80) <0.001
rMSSD, ms 15.0 (11.0–23.0) 15.0 (11.0–23.0) 17.0 (11.0–28.0) 0.022
LF, Hz 5.7 (3.4–10.2) 5.7 (3.4–9.9) 5.9 (3.3–11.6) 0.215
HF, Hz 5.3 (3.8–8.3) 5.3 (3.8–8.2) 5.9 (4.0–10.8) 0.075
LF/HF ratio 1.0 (0.8–1.4) 1.0 (0.8–1.4) 1.0 (0.8–1.4) 0.916

AF, atrial fibrillation; AFCA, atrial fibrillation catheter ablation; BMI, body mass index; DM, diabetes mellitus; E/e’, ratio of early diastolic mitral inflow velocity to early diastolic mitral annulus velocity; HF, high frequency; HTN, hypertension; EF, ejection fraction; LA, left atrium; LAVI, left atrial volume index; LF, low frequency; PV, pulmonary vein; RA, right atrium; rMSSD, root mean square of differences between successive RR intervals.